Superluminal Medicines, Inc.

Biotechnology company · Boston, Massachusetts, United States

Superluminal Medicines, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Superluminal Medicines at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2023

SEC CIK1989478

What does Superluminal Medicines do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $5 million sold (2025).

Frequently asked questions about Superluminal Medicines

Where is Superluminal Medicines headquartered?

Superluminal Medicines, Inc. is headquartered in Boston, Massachusetts, United States.

What does Superluminal Medicines do?

Superluminal Medicines, Inc. is a biotechnology company.

When was Superluminal Medicines founded?

The earliest incorporation on record for Superluminal Medicines, Inc. is in 2023, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences